0.3423

4.57% -0.0164

Pre-market: .35 0.0077 +2.25%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $0.3423, with a volume of 1.07M. It is down -4.57% in the last 24 hours and up +5.58% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$0.3587

Open:

$0.374

24h Volume:

1.07M

Relative Volume:

0.05

Market Cap:

$13.19M

Revenue:

$7.11M

Net Income/Loss:

$-41.28M

P/E Ratio:

-0.248

EPS:

-1.38

Net Cash Flow:

$-26.84M

1W Performance:

-13.60%

1M Performance:

+5.58%

6M Performance:

+20.06%

1Y Performance:

-68.01%

1-Day Range:

$0.3362

$0.38

1-Week Range:

$0.3111

$0.40

52-Week Range:

$0.2275

$1.55

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1130)

Industry

Medical Devices (144)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

132

Twitter

@Co_Diagnostics

Next Earnings Date

2024-11-07

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	0.3423	21.84M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	126.15	226.05B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	97.01	147.09B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	364.23	137.49B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	100.34	129.29B	34.76B	4.79B	5.30B	3.7049
EW Edwards Lifesciences Corp	86.02	48.77B	5.88B	1.34B	799.60M	2.3489

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

12:17 PM

Can Co Diagnostics Inc. stock hit analyst price targetsJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com

12:17 PM

Nov 19, 2025

Co-Diagnostics (CODX) Q3 2025 Earnings Transcript - AOL.com

Nov 19, 2025

Will Co Diagnostics Inc. stock attract ESG investorsJuly 2025 Setups & Fast Entry High Yield Tips - newser.com

Nov 19, 2025

Chart overlay techniques for tracking Co Diagnostics Inc.2025 Top Decliners & Intraday High Probability Alerts - newser.com

Nov 19, 2025

Why Co Diagnostics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - newser.com

Nov 19, 2025

What technical models suggest about Co Diagnostics Inc.’s comebackTrade Volume Report & Weekly Setup with ROI Potential - newser.com

Nov 19, 2025

Nov 18, 2025

Will Co Diagnostics Inc. stock benefit from AI adoptionWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com

Nov 18, 2025

How sentiment analysis helps forecast Co Diagnostics Inc.2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com

Nov 18, 2025

Co-Diagnostics Earnings Call: Strategic Moves Amid Financial Struggles - MSN

Nov 18, 2025

How Co Diagnostics Inc. stock trades during market volatilityWeekly Market Outlook & AI Powered Trade Plan Recommendations - newser.com

Nov 18, 2025

Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dxtm PCR Platform to Support Submission to the U.S. FDA - Lelezard

Nov 18, 2025

Co-Diagnostics initiates clinical evaluations for upper respiratory multiplex point-of-care test on Co-Dx(TM) PCR platform to support submission to the U.S. FDA - MarketScreener

Nov 18, 2025

Co-Diagnostics (CODX) begins Co-Dx PCR Flu A/B, COVID-19, RSV point-of-care evaluations - Stock Titan

Nov 18, 2025

Nov 16, 2025

Sentiment analysis tools applied to Co Diagnostics Inc.July 2025 Volume & Community Consensus Picks - newser.com

Nov 16, 2025

Predicting Co Diagnostics Inc. trend using moving averagesBear Alert & Detailed Earnings Play Strategies - newser.com

Nov 16, 2025

What recovery options are there for Co Diagnostics Inc.July 2025 Fed Impact & Accurate Buy Signal Notifications - newser.com

Nov 16, 2025

Is Co Diagnostics Inc. stock a top momentum playJuly 2025 Fed Impact & Community Verified Trade Signals - newser.com

Nov 16, 2025

Nov 15, 2025

Is Co Diagnostics Inc. stock attractive after correctionEarnings Beat & Daily Market Momentum Tracking - newser.com

Nov 15, 2025

Will Co Diagnostics Inc. stock remain a Wall Street favoriteJuly 2025 Earnings & Daily Stock Trend Reports - newser.com

Nov 15, 2025

Nov 14, 2025

Is Co Diagnostics Inc. stock positioned well for digital economyDay Trade & Verified High Yield Trade Plans - Fundação Cultural do Pará

Nov 14, 2025

Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025

What margin trends mean for Co Diagnostics Inc. stockJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - Fundação Cultural do Pará

Nov 14, 2025